Cargando…
Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing?
A recent study by Forceville and colleagues evaluated the effect of high-dose selenium administration as a treatment for septic shock. The study was negative and conflicts with existing clinical data regarding selenium administration in critically ill patients. Perhaps the key to understanding the d...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206521/ https://www.ncbi.nlm.nih.gov/pubmed/17692136 http://dx.doi.org/10.1186/cc5975 |
| _version_ | 1782148491617763328 |
|---|---|
| author | Heyland, Daren K |
| author_facet | Heyland, Daren K |
| author_sort | Heyland, Daren K |
| collection | PubMed |
| description | A recent study by Forceville and colleagues evaluated the effect of high-dose selenium administration as a treatment for septic shock. The study was negative and conflicts with existing clinical data regarding selenium administration in critically ill patients. Perhaps the key to understanding the differences between these discrepant observations lies in considering the dose and timing of selenium administration. |
| format | Text |
| id | pubmed-2206521 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2007 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-22065212008-01-19 Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing? Heyland, Daren K Crit Care Commentary A recent study by Forceville and colleagues evaluated the effect of high-dose selenium administration as a treatment for septic shock. The study was negative and conflicts with existing clinical data regarding selenium administration in critically ill patients. Perhaps the key to understanding the differences between these discrepant observations lies in considering the dose and timing of selenium administration. BioMed Central 2007 2007-08-07 /pmc/articles/PMC2206521/ /pubmed/17692136 http://dx.doi.org/10.1186/cc5975 Text en Copyright © 2007 BioMed Central Ltd |
| spellingShingle | Commentary Heyland, Daren K Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing? |
| title | Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing? |
| title_full | Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing? |
| title_fullStr | Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing? |
| title_full_unstemmed | Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing? |
| title_short | Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing? |
| title_sort | selenium supplementation in critically ill patients: can too much of a good thing be a bad thing? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206521/ https://www.ncbi.nlm.nih.gov/pubmed/17692136 http://dx.doi.org/10.1186/cc5975 |
| work_keys_str_mv | AT heylanddarenk seleniumsupplementationincriticallyillpatientscantoomuchofagoodthingbeabadthing |